Company Filing History:
Years Active: 2020
Title: Abhishek Gupta: Innovator in Dry Powder Blending Technology
Introduction
Abhishek Gupta is a notable inventor based in Pembroke Pines, Florida. He has made significant contributions to the field of pharmaceutical manufacturing, particularly in the area of dry powder blending. His innovative approach has the potential to enhance the efficiency and effectiveness of pharmaceutical formulations.
Latest Patents
Abhishek Gupta holds a patent for a process for manufacturing dry powder blends. This invention focuses on the processes involved in dry powder blending of both pharmaceutical and non-pharmaceutical solid particulate matter and powders. Specifically, it addresses the blending of microparticles and the creation of dry powder blends intended for pharmaceutical use. The patented process involves the preparation of a dry microparticulate powder blend that includes one or more micronized active pharmaceutical ingredients (APIs) and may also incorporate pharmaceutically acceptable carriers and excipients. The key feature of this process is the 'pulsating blending' technique, which optimizes the mixing of the ingredients.
Career Highlights
Abhishek Gupta is currently associated with Lupin Atlantis Holdings SA, where he applies his expertise in pharmaceutical manufacturing. His work focuses on developing innovative solutions that improve the quality and performance of pharmaceutical products. His dedication to research and development has positioned him as a valuable asset in the industry.
Collaborations
Abhishek has collaborated with notable colleagues, including Herbert Clark Chiou and Samiran De. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical technology.
Conclusion
Abhishek Gupta's contributions to the field of dry powder blending represent a significant advancement in pharmaceutical manufacturing. His innovative processes have the potential to improve the formulation of medications, ultimately benefiting patients and the healthcare industry.